EcoDrugPlus

Protein Tyrosine Kinase 6

Ensembl ID : ENSFCAG00000033150
Gene Symbol: PTK6
5 Cross references
174 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSFCAG00000009695
Gene Symbol: PTPN11
5 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSFCAG00000009906
Gene Symbol: PTPRB
5 Cross references
268 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSFCAG00000006934
Gene Symbol: PNP
5 Cross references
123 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSFCAG00000005082
Gene Symbol: P2RX3
5 Cross references
272 Possible Orthologues:

Purinergic Receptor P2x 7

Ensembl ID : ENSFCAG00000012451
Gene Symbol: P2RX7
5 Cross references
195 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSFCAG00000013018
Gene Symbol: P2RY1
5 Cross references
191 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSFCAG00000032749
Gene Symbol: P2RY2
5 Cross references
200 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSFCAG00000008157
Gene Symbol: P2RY4
5 Cross references
168 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSFCAG00000035630
Gene Symbol: P2RY6
3 Cross references
183 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSFCAG00000027462
Gene Symbol: RAMP1
5 Cross references
252 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSFCAG00000014625
Gene Symbol: RIPK1
5 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).